HealthVerity与Recursion合作，利用真实世界数据增强临床试验分析-动脉网

HealthVerity Partners with Recursion to Enhance Clinical Trial Analytics with Real-World Data

CISION 等信源发布 2025-04-16 20:30



可切换为仅中文







PHILADELPHIA

费城

，

April 16, 2025

2025年4月16日

/PRNewswire/ -- HealthVerity, the leader in real-world data (RWD) technology and privacy-compliant data exchange, today announced that Recursion (NASDAQ:

/PRNewswire/ -- HealthVerity，真实世界数据（RWD）技术和隐私合规数据交换的领导者，今天宣布Recursion（纳斯达克股票代码：

RXRX

), a leading clinical stage TechBio company decoding biology to radically improve lives, has licensed its real-world data to enhance clinical trial design and analytics.

），一家处于临床阶段的领先技术生物公司，通过解读生物学来彻底改善生活，已将其真实世界数据授权用于改进临床试验设计和分析。

Through this agreement, Recursion will integrate HealthVerity de-identified data for over

通过该协议，Recursion将整合HealthVerity的去标识化数据，涵盖超过

340M

covered lives within the US into its advanced data science and machine learning platforms, the Recursion OS, allowing for deeper insights into patient populations, enhanced trial design and feasibility assessments, as well as clinical operations workflows. By leveraging these high-quality, linked data assets, Recursion seeks to industrialize clinical development, reduce costs, and accelerate the development of novel therapeutics..

美国境内的覆盖人群被纳入其先进的数据科学和机器学习平台——Recursion OS，这使得对患者群体的深入洞察、强化的试验设计和可行性评估以及临床操作流程成为可能。通过利用这些高质量的关联数据资产，Recursion旨在实现临床开发的工业化、降低成本并加速新型疗法的开发。

'Our partnership with Recursion underscores the transformative potential of real-world data in driving smarter clinical trials,' said

“我们与Recursion的合作突显了现实世界数据在推动更智能的临床试验方面的变革潜力，”

Andrew Kress

安德鲁·克雷斯

, CEO of HealthVerity. 'By providing seamless access to the industry's most comprehensive and interoperable real-world data, we empower innovators like Recursion to make data-driven decisions that streamline clinical development.'

HealthVerity首席执行官表示：“通过提供对行业内最全面且可互操作的真实世界数据的无缝访问，我们赋能像Recursion这样的创新者做出数据驱动的决策，从而优化临床开发流程。”

Recursion's proprietary AI-driven approach relies on integrating diverse datasets and AI/ML models to identify novel insights into human biology and molecule design. The incorporation of real-world data from HealthVerity Marketplace will further strengthen Recursion's ability to predict patient responses, refine study designs, and ensure clinical trial sites are positioned to meet enrollment goals..

Recursion 专有的人工智能驱动方法依赖于整合不同的数据集和 AI/ML 模型，以发现有关人类生物学和分子设计的新见解。HealthVerity Marketplace 的真实世界数据的引入将进一步增强 Recursion 预测患者反应、优化研究设计以及确保临床试验点能够实现招募目标的能力。

'With the majority of the industry's time and resources focused on clinical trials, we see a significant opportunity to transform how clinical development is designed and executed,' said

“随着业界大部分时间和资源集中在临床试验上，我们看到了一个巨大的机会，可以改变临床开发的设计和执行方式，”

Najat Khan

纳贾特·汗

, PhD, Chief R&D Officer and Chief Commercial Officer at Recursion. 'By integrating privacy-compliant real-world data from HealthVerity into Recursion OS, we are advancing our mission to optimize trial design through in silico simulations, accelerate recruitment through a patient-centric approach that includes underserved populations, and generate stronger evidence to inform development and regulatory decisions.

博士，Recursion的首席研发官兼首席商务官。 “通过将HealthVerity的符合隐私要求的真实世界数据整合到Recursion操作系统中，我们正在推进我们的使命，即通过计算机模拟优化试验设计，通过以患者为中心的方法加速招募，包括服务不足的人群，并生成更有力的证据以指导开发和监管决策。

By doing so, we are not only streamlining clinical development but also ensuring that we bring more impactful, life-changing treatments to patients faster and more efficiently'.

通过这样做，我们不仅简化了临床开发流程，还确保能更快、更有效地为患者带来更有影响力、改变生命的治疗方案。

The HealthVerity approach to real-world data acquisition and governance ensures compliance with HIPAA and other regulatory frameworks while maintaining the highest standards of patient privacy. By combining data from the nation's largest healthcare data ecosystem, HealthVerity enables precise patient journey insights, supporting clinical development, regulatory submissions, and post-market studies..

HealthVerity 的真实世界数据获取与治理方法确保符合 HIPAA 和其他监管框架，同时保持患者隐私的最高标准。通过整合来自美国最大规模医疗数据生态系统的数据，HealthVerity 能够提供精准的患者旅程洞察，支持临床开发、监管提交和上市后研究。

For more information, visit

欲了解更多信息，请访问

www.healthverity.com

。

About HealthVerity

关于HealthVerity

HealthVerity is the leader in privacy-protected real-world data exchange, transforming how healthcare and life sciences organizations connect and analyze disparate patient data. By enabling access to the industry's largest RWD ecosystem, HealthVerity supports critical applications in clinical development, commercial strategy, and regulatory decision-making..

HealthVerity 是隐私保护现实世界数据交换的领导者，正在改变医疗保健和生命科学组织连接和分析分散的患者数据的方式。通过提供对行业内最大的真实世界数据 (RWD) 生态系统的访问，HealthVerity 支持临床开发、商业战略和监管决策中的关键应用。

About Recursion

关于递归

Recursion (NASDAQ:

递归 (NASDAQ:

RXRX

) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world's largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias.

)是一家处于临床阶段的科技生物公司，通过解码生物学来彻底改善生活，引领行业发展。实现其使命的核心是Recursion操作系统，这一平台整合了多种技术，持续生成世界上规模最大的专属生物和化学数据集之一。Recursion利用先进的机器学习算法，从数据集中提炼出数万亿条跨越生物学和化学的可搜索关系，且不受人类偏见的限制。

By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology, and chemistry to advance the future of medicine..

通过指挥大规模的实验规模 —— 每周多达数百万次湿实验室实验 —— 以及巨大的计算规模 —— 拥有并运营世界上最强劲的超级计算机之一，Recursion 正在将技术、生物学和化学结合起来，推动医学的未来。

Media Contact:

媒体联系人:

HealthVerity

健康权威

info@healthverity.com

Recursion

递归

media@recursion.com

媒体@递归公司.com

SOURCE HealthVerity, Inc.

来源：HealthVerity, Inc.